The effect of reduction of class II antigens on the survival of pancreatic allografts.
Spillenaar-Bilgen
E J
EJ
Department of Surgery, Erasmus University, Rotterdam, The Netherlands.
Bouwman
E
E
de Bruin
R W
RW
Marquet
R L
RL
Jeekel
J
J
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003921:Diabetes Mellitus, Experimental / Q000601:surgery; D006085:Graft Survival; D000949:Histocompatibility Antigens Class II / Q000032:analysis / Q000276:immunology*; D007165:Immunosuppression Therapy; D007167:Immunotherapy; D007515:Islets of Langerhans / Q000276:immunology; D016381:Islets of Langerhans Transplantation; D051381:Rats; D011914:Rats, Inbred BN; D011919:Rats, Inbred Strains; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D000949:Histocompatibility Antigens Class II